ArticleCancers2023

Phase I Study of a Combination of Fluvastatin and Celecoxib in Children with Relapsing/Refractory Low-Grade or High-Grade Glioma (FLUVABREX).

Pierre Leblond et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.